ProfileGDS4718 / 235367_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 50% 57% 46% 48% 53% 43% 47% 52% 63% 52% 48% 52% 48% 46% 47% 46% 50% 46% 47% 46% 54% 51% 47% 45% 47% 48% 46% 45% 46% 46% 47% 47% 51% 50% 44% 43% 43% 54% 50% 45% 48% 46% 43% 44% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.5020650
GSM549102patient 115, normal, homogenized [OPG study]5.9270757
GSM549104patient 119, normal, homogenized [OPG study]5.26246
GSM549108patient 138, normal, homogenized [OPG study]5.4394448
GSM549119patient 077, normal, homogenized [OPG study]5.6729753
GSM549133patient 032, cancer, homogenized [OPG study]5.0651343
GSM549139patient 042, cancer, homogenized [OPG study]5.3168147
GSM549099patient 107, normal, homogenized [OPG study]5.6497752
GSM549109patient 139, normal, homogenized [OPG study]6.3558663
GSM549110patient 046, normal, homogenized [OPG study]5.637452
GSM549114patient 063, normal, homogenized [OPG study]5.3719548
GSM549122patient 082, normal, homogenized [OPG study]5.643552
GSM549134patient 033, cancer, homogenized [OPG study]5.3645948
GSM549136patient 036, cancer, homogenized [OPG study]5.2117146
GSM549140patient 044, cancer, homogenized [OPG study]5.2860747
GSM549111patient 047, normal, homogenized [OPG study]5.2461946
GSM549113patient 057, normal, homogenized [OPG study]5.4843650
GSM549132patient 031, cancer, homogenized [OPG study]5.2733846
GSM549137patient 038, cancer, homogenized [OPG study]5.3182647
GSM549142patient 047, cancer, homogenized [OPG study]5.4342146
GSM549100patient 110, normal, homogenized [OPG study]5.7551154
GSM549107patient 135, normal, homogenized [OPG study]5.5577951
GSM549115patient 068, normal, homogenized [OPG study]5.3122347
GSM549116patient 072, normal, homogenized [OPG study]5.2414645
GSM549120patient 078, normal, homogenized [OPG study]5.3419947
GSM549131patient 030, cancer, homogenized [OPG study]5.337548
GSM549118patient 074, normal, homogenized [OPG study]5.2800446
GSM549129patient 027, cancer, homogenized [OPG study]5.2357245
GSM549123patient 088, normal, homogenized [OPG study]5.2895546
GSM549124patient 006, cancer, homogenized [OPG study]5.3356846
GSM549126patient 015, cancer, homogenized [OPG study]5.3334747
GSM549128patient 025, cancer, homogenized [OPG study]5.3283947
GSM549103patient 117, normal, homogenized [OPG study]5.6404751
GSM549117patient 073, normal, homogenized [OPG study]5.4447750
GSM549138patient 041, cancer, homogenized [OPG study]5.1593644
GSM549141patient 045, cancer, homogenized [OPG study]5.1023643
GSM549130patient 028, cancer, homogenized [OPG study]5.1666243
GSM549101patient 111, normal, homogenized [OPG study]5.7480954
GSM549105patient 128, normal, homogenized [OPG study]5.5329550
GSM549106patient 134, normal, homogenized [OPG study]5.1666245
GSM549112patient 048, normal, homogenized [OPG study]5.4094148
GSM549125patient 011, cancer, homogenized [OPG study]5.3181746
GSM549127patient 024, cancer, homogenized [OPG study]5.1160243
GSM549135patient 035, cancer, homogenized [OPG study]5.1496144